Kongzhen Hu
- Oncology top 5%
- Peptidase Inhibition and Analysis 28
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 11
-
- Radiopharmaceutical Chemistry and Applications 22
- Medical Imaging Techniques and Applications 14
-
- Neuropeptides and Animal Physiology 7
-
- Amino Acid Enzymes and Metabolism 8
-
- Cardiac Structural Anomalies and Repair 13
-
- Nanoplatforms for cancer theranostics 6
- Co-authors
- Shun HuangHubing WuYanjiang HanHongsheng LiGanghua TangLijuan WangLiang XiangHongliang Wang
- Partner nations
- ChinaUnited States
In The Last Decade
Kongzhen Hu
60 papers receiving 912 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 487
- Cancer Research 236
- Radiology, Nuclear Medicine and Imaging 322
- Cellular and Molecular Neuroscience 125
- Biochemistry 42
Countries citing papers authored by Kongzhen Hu
This map shows the geographic impact of Kongzhen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kongzhen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kongzhen Hu more than expected).
Fields of papers citing papers by Kongzhen Hu
This network shows the impact of papers produced by Kongzhen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kongzhen Hu. The network helps show where Kongzhen Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kongzhen Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 1 | |
| 9 | Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancerbreakdown → | 2022 | 117 |
| 10 | 2022 | 17 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 23 | |
| 13 | 2021 | 83 | |
| 14 | 2021 | 0 | |
| 15 | 2020 | 10 | |
| 16 | 2019 | 27 | |
| 17 | 2017 | 4 | |
| 18 | 2015 | 11 | |
| 19 | 2013 | 14 | |
| 20 | Progress of the methods for 18 F-labeled peptides | 2012 | 0 |
About Kongzhen Hu
Kongzhen Hu is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Biochemistry, having authored 64 papers that have together received 918 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (28 papers), Radiopharmaceutical Chemistry and Applications (22 papers), Medical Imaging Techniques and Applications (14 papers), Cardiac Structural Anomalies and Repair (13 papers), Protease and Inhibitor Mechanisms (11 papers), Amino Acid Enzymes and Metabolism (8 papers), Neuropeptides and Animal Physiology (7 papers) and Nanoplatforms for cancer theranostics (6 papers). The work is most often cited by research in Oncology (487 citations), Cancer Research (236 citations) and Radiology, Nuclear Medicine and Imaging (322 citations). Kongzhen Hu has collaborated with scholars based in China and United States. Frequent co-authors include Shun Huang, Hubing Wu, Yanjiang Han, Hongsheng Li, Ganghua Tang, Lijuan Wang, Liang Xiang, Ganghua Tang, Hongliang Wang and Ganghua Tang. Their work appears in journals such as PLoS ONE, Radiology and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.